Annovis Bio, Inc. (ANVS)
3.79
-0.41
(-9.76%)
USD |
NYSE |
Dec 11, 16:00
3.66
-0.13
(-3.43%)
Pre-Market: 07:08
Annovis Bio EPS Diluted (Quarterly): -0.3689 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.263M |
| Total Expenses (Quarterly) | 7.263M |
| Enterprise Value | 85.16M |
| Earnings Yield | -39.14% |
| Normalized Earnings Yield | -40.60 |